CEL SCI CORP
For the period ended Sep 30, 2024. Filed Jan 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jan 13, 2025
CVM$1.41+4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
| 2024 | 2023 | |
|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net loss | $(26,920,465) | $(32,194,303) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 3,969,183 | 3,958,334 |
| Non-cash lease expense | 4,873 | 15,292 |
| Share-based payments for services | 858,498 | 655,740 |
| Equity based compensation | 4,270,180 | 6,286,231 |
| Common stock contributed to 401(k) plan | 218,717 | 207,593 |
| (Increase)/decrease in assets: | ||
| Prepaid expenses | 72,674 | 151,935 |
| Supplies used for R&D and manufacturing | (172,608) | (156,727) |
| Deposits | 745 | (2,323,346) |
| Increase/(decrease) in liabilities: | ||
| Accounts payable | (460,576) | 257,845 |
| Accrued expenses | (458,489) | 207,089 |
| Due to employees | (193,938) | 85,756 |
| Net cash used in operating activities | (18,811,206) | (22,848,561) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchases of property and equipment | (94,875) | (361,892) |
| Expenditures for patent costs | (13,211) | (10,370) |
| Net cash used in investing activities | (108,086) | (372,262) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Proceeds from issuance of common stock and pre-funded warrants | 23,575,000 | 6,552,497 |
| Payments of stock issuance costs | (2,370,513) | (744,913) |
| Proceeds from the purchase of stock by officers and directors | 80,620 | - |
| Proceeds from the exercise of warrants | - | 447,291 |
| Payments on obligations under finance leases | (1,773,377) | (1,560,455) |
| Proceeds from related party loans | 450,000 | - |
| Payments of related party loans | (450,000) | - |
| Net cash provided by financing activities | 19,511,730 | 4,694,420 |
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 592,438 | (18,526,403) |
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 4,145,735 | 22,672,138 |
| CASH AND CASH EQUIVALENTS, END OF YEAR | $4,738,173 | $4,145,735 |
STATEMENTS OF CASH FLOWS
| SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||||
|---|---|---|---|---|
| 2024 · 2023 | ||||
| Property and equipment purchases included in current liabilities | $32,954 | $51,650 | ||
| Capitalized patent costs included in current liabilities | $ | - | $13,211 | |
| Assets purchased under finance leases | $20,797 | $ | - | |
| Finance lease obligation included in accounts payable | $1,320 | $1,451 | ||
| Consulting services paid with issuance of common stock | $759,901 | $565,980 | ||
| Financing costs included in current liabilities | $38,950 | $77,703 | ||
| Accrued consulting services to be paid with common stock | $ | - | $55,000 | |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOWS: | ||||
| Cash paid for interest | $923,807 | $1,062,564 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.